Search

Showing "11154" results for ""

Put your questions on HIV to world leaders

5 million new HIV cases in 2003, say UNAIDS

Thickness of fat around the kidneys predicts which HIV-positive patients will get lipodystrophy

Viral load above 100,000 linked with risk of severe side-effects in people taking PI-based HAART

Thai policy on drugs threatens HIV prevention successes, warns Human Rights Watch

HIV could have catastrophic economic consequences for Asia/Pacific, warns report

FDA warns that tenofovir has not been proven to be safe for HIV/HBV coinfection

BHIVA audit shows good management of HIV and pregnancy in UK

Intergrase inhibitor trial results have potential implications for treatment strategies

Azithromycin resistant syphilis found in HIV-positive gay men

Long-term stress suppresses immune system, particularly in those who are sick, finds meta-analysis

Once daily Reverset safe and effective over ten days in treatment-naïve and –experienced patients

Tenofovir has viral potency, a good lipid and safety profile, and should be available for first line HAART says study

Efavirenz can be used at normal dose with rifampicin, Thais report

WHO: we are still on track for 3 x 5 HIV treatment goal

Taking HAART not associated with sexual risk taking, but belief that HAART makes HIV less infectious is, finds meta-analysis

Could monotherapy with Kaletra become an option for HIV treatment?

IAS issue updated HIV treatment guidelines for rich countries

Receive the latest HIV research and conference news

Showing "11154" results for ""

Put your questions on HIV to world leaders

5 million new HIV cases in 2003, say UNAIDS

Thickness of fat around the kidneys predicts which HIV-positive patients will get lipodystrophy

Viral load above 100,000 linked with risk of severe side-effects in people taking PI-based HAART

Thai policy on drugs threatens HIV prevention successes, warns Human Rights Watch

HIV could have catastrophic economic consequences for Asia/Pacific, warns report

FDA warns that tenofovir has not been proven to be safe for HIV/HBV coinfection

BHIVA audit shows good management of HIV and pregnancy in UK

Intergrase inhibitor trial results have potential implications for treatment strategies

Azithromycin resistant syphilis found in HIV-positive gay men

Long-term stress suppresses immune system, particularly in those who are sick, finds meta-analysis

Once daily Reverset safe and effective over ten days in treatment-naïve and –experienced patients

Tenofovir has viral potency, a good lipid and safety profile, and should be available for first line HAART says study

Efavirenz can be used at normal dose with rifampicin, Thais report

WHO: we are still on track for 3 x 5 HIV treatment goal

Taking HAART not associated with sexual risk taking, but belief that HAART makes HIV less infectious is, finds meta-analysis

Could monotherapy with Kaletra become an option for HIV treatment?

IAS issue updated HIV treatment guidelines for rich countries

Receive the latest HIV research and conference news